This project will establish an advanced genomic platform to enhance detection and prevention of bacterial infections in children and young people that cause serious morbidity and, in some cases, mortality, in children and young people. With state-of-the-art pathogen genomics technology, our team will provide the people of the HNE regions with timely and efficient infectious disease monitoring that will speed up the time to diagnosis, increase the precision and accuracy of the treatments required.

Our early career researchers, supported by the overall project team, are uniquely positioned to build on their combined strengths in clinical and laboratory research to embed world class microbiome research into current diagnostics and provide communities with access to health services that reduce the pain and distress from childhood infectious diseases. Using nanopore technology, our future goal is to provide our clinicians with whole-genome sequencing results within 24 hours, providing sufficient time for intervention and management.